|
⚲
|
| Keyboard |
| Zante Greg
✚
|
|
|---|---|
| CIK # | 0001264949 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001264949] | |
| 4 | [0001264949] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Viking Therapeutics Inc | |
| Zante Greg |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 1,500 | $32.09 | 48,135 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 10,300 | $34.24 | 352,672 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 13,900 | $33.38 | 463,982 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 31,961 | $32.30 | 1,032,340 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-02 | Grant | 32,049 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 91,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-02 | Grant | 41,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-10-28 | Sell | 6,185 | $35.00 | 216,475 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-10-27 | Grant | 11,117 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-07-03 | Sell | 4,266 | $27.76 | 118,424 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-07-02 | Grant | 7,667 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-06 | Sell | 4,700 | $43.32 | 203,604 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-06 | Sell | 45,609 | $42.69 | 1,947,048 |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2025-01-03 | Grant | 37,200 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-03 | Grant | 44,533 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-03 | Grant | 21,667 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-10-28 | Sell | 7,967 | $80.65 | 642,539 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-10-28 | Option exercise | 51,000 | $8.52 | 434,520 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-10-28 | Sell | 49,672 | $74.56 | 3,703,544 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-10-28 | Sell | 18,620 | $75.79 | 1,411,210 |
| showing 20 of 104 most recent transactions | |||||